EP4258874A4 - ANTIVIRAL OLIVE EXTRACT COMPOSITIONS AND METHODS - Google Patents
ANTIVIRAL OLIVE EXTRACT COMPOSITIONS AND METHODS Download PDFInfo
- Publication number
- EP4258874A4 EP4258874A4 EP21904253.8A EP21904253A EP4258874A4 EP 4258874 A4 EP4258874 A4 EP 4258874A4 EP 21904253 A EP21904253 A EP 21904253A EP 4258874 A4 EP4258874 A4 EP 4258874A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antiviral
- methods
- olive extract
- extract compositions
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/22—Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/775—Phenolic resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Environmental Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Alternative & Traditional Medicine (AREA)
- Pest Control & Pesticides (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063122893P | 2020-12-08 | 2020-12-08 | |
| US17/326,146 US11951143B2 (en) | 2017-01-04 | 2021-05-20 | Olive oil use |
| PCT/US2021/062213 WO2022125552A1 (en) | 2020-12-08 | 2021-12-07 | Antiviral olive extract compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4258874A1 EP4258874A1 (en) | 2023-10-18 |
| EP4258874A4 true EP4258874A4 (en) | 2024-12-18 |
Family
ID=81973957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP21904253.8A Pending EP4258874A4 (en) | 2020-12-08 | 2021-12-07 | ANTIVIRAL OLIVE EXTRACT COMPOSITIONS AND METHODS |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4258874A4 (en) |
| CA (1) | CA3201770A1 (en) |
| WO (1) | WO2022125552A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117844A (en) * | 1994-11-07 | 2000-09-12 | F&S Group, Inc. | Method and composition for antiviral therapy |
| US20020110600A1 (en) * | 2001-02-15 | 2002-08-15 | John Voorhees | Composition for treating symptoms of influenza |
| WO2008143137A1 (en) * | 2007-05-24 | 2008-11-27 | National University Corporation, Obihiro University Of Agriculture And Veterinary Medicine | Antiviral agent |
| US20200138843A1 (en) * | 2018-11-06 | 2020-05-07 | ATLAS OLIVE OILS Sarl. | Compositions for treating pain and inflammation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6416808B1 (en) * | 2000-09-01 | 2002-07-09 | Creagri, Inc. | Method of obtaining a hydroxytyrosol-rich composition from vegetation water |
| US20090061031A1 (en) * | 2006-07-07 | 2009-03-05 | Sylvia Lee-Huang | Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus |
| EP2635120A1 (en) * | 2010-08-06 | 2013-09-11 | Phyto Innovative Products Ltd | Compositions comprising oleuropeins and flavanoids and their use |
| US8846114B1 (en) * | 2013-09-05 | 2014-09-30 | Oleavicin, LLC | Composition for the treatment of herpes and cold sores |
-
2021
- 2021-12-07 EP EP21904253.8A patent/EP4258874A4/en active Pending
- 2021-12-07 WO PCT/US2021/062213 patent/WO2022125552A1/en not_active Ceased
- 2021-12-07 CA CA3201770A patent/CA3201770A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117844A (en) * | 1994-11-07 | 2000-09-12 | F&S Group, Inc. | Method and composition for antiviral therapy |
| US20020110600A1 (en) * | 2001-02-15 | 2002-08-15 | John Voorhees | Composition for treating symptoms of influenza |
| WO2008143137A1 (en) * | 2007-05-24 | 2008-11-27 | National University Corporation, Obihiro University Of Agriculture And Veterinary Medicine | Antiviral agent |
| US20200138843A1 (en) * | 2018-11-06 | 2020-05-07 | ATLAS OLIVE OILS Sarl. | Compositions for treating pain and inflammation |
Non-Patent Citations (3)
| Title |
|---|
| See also references of WO2022125552A1 * |
| SUN ZIQI ET AL: "Future antiviral surfaces: Lessons from COVID-19 pandemic", SUSTAINABLE MATERIALS AND TECHNOLOGIES, vol. 25, 1 September 2020 (2020-09-01), pages e00203, XP055795359, ISSN: 2214-9937, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376362/pdf/main.pdf> DOI: 10.1016/j.susmat.2020.e00203 * |
| YAMADA K ET AL: "Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, vol. 83, no. 1, 1 July 2009 (2009-07-01), pages 35 - 44, XP026149756, ISSN: 0166-3542, [retrieved on 20090324], DOI: 10.1016/J.ANTIVIRAL.2009.03.002 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3201770A1 (en) | 2022-06-16 |
| WO2022125552A1 (en) | 2022-06-16 |
| EP4258874A1 (en) | 2023-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4153604A4 (en) | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREFOR | |
| EP3823673A4 (en) | ANTI-CD112R COMPOSITIONS AND METHODS | |
| EP3891284A4 (en) | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | |
| EP4240168A4 (en) | MILK-LIKE COMPOSITIONS AND RELATED METHODS | |
| EP3826638A4 (en) | ELAGOLIX SODIUM COMPOSITIONS AND METHODS | |
| EP4196488A4 (en) | CLEAVABLE LINKER COMPOSITIONS AND METHODS | |
| EP3625229C0 (en) | SOLID FORMS OF BERBERINE URSODEOXYCHOLATE AND COMPOSITIONS AND METHODS THEREFOR | |
| JP2018172409A5 (en) | Compositions comprising 15-HEPE and methods of using same | |
| EP4146151A4 (en) | FURAN-SURFACTANT COMPOSITIONS AND METHODS | |
| EP4347859A4 (en) | INTEGRASE COMPOSITIONS AND METHODS | |
| EP3737391A4 (en) | COMPOSITIONS AND METHODS TARGETED AGAINST CD99-EXPRESSING CANCER | |
| PL4208046T3 (en) | Compositions and methods | |
| EP3844500A4 (en) | RP182 COMPOSITIONS AND METHODS | |
| EP4243867A4 (en) | MULTI-PURPOSE SUPPORTS AND ASSOCIATED VACCINE COMPOSITIONS | |
| EP4387986A4 (en) | Milk-like compositions and related processes | |
| EP4463173A4 (en) | Postbiotic compositions and methods | |
| EP4367198A4 (en) | GEOPOLYMER COMPOSITIONS AND PROCESSES | |
| EP4419677A4 (en) | DNA COMPOSITIONS AND RELATED METHODS | |
| IL309079A (en) | methods and compositions | |
| EP4179117A4 (en) | FETAL TROPHOBLAST COMPOSITIONS AND METHODS | |
| EP4165060A4 (en) | VACCINE COMPOSITIONS, METHODS AND USES THEREOF | |
| EP3697783C0 (en) | BROAD SPECTRUM ANTIVIRAL COMPOSITIONS AND METHODS | |
| EP4084784A4 (en) | COMPOSITIONS AND METHODS | |
| EP3890769A4 (en) | COMPOSITIONS OF MANIPULATED FLAGELLIN AND USES | |
| EP4401649A4 (en) | EXCLUSION DEVICES AND RELATED METHODS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20230710 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20241114 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 47/14 20170101ALI20241108BHEP Ipc: A61K 9/08 20060101ALI20241108BHEP Ipc: A61K 31/192 20060101ALI20241108BHEP Ipc: A61P 31/12 20060101ALI20241108BHEP Ipc: A61K 31/351 20060101ALI20241108BHEP Ipc: A61K 31/05 20060101ALI20241108BHEP Ipc: A61K 9/06 20060101ALI20241108BHEP Ipc: A01N 35/02 20060101ALI20241108BHEP Ipc: A01N 31/08 20060101ALI20241108BHEP Ipc: A01N 27/00 20060101AFI20241108BHEP |